Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis

References

• Ben Sahra I, Le Marchand-Brustel Y, Tanti JF, Bost F. 2010. Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Mol Cancer Ther. 9:1092–1099.
   PubMed Web of Science ®Google Scholar
• Bodmer M, Becker C, Meier C, Jick SS, Meier CR. 2012. Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 21:280–286.
   PubMed Web of Science ®Google Scholar
• Cardel M, Jensen SM, Pottegard A, Jorgensen TL, Hallas J. 2014. Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case-control study. Cancer Med. 3:1458–1466.
   PubMed Web of Science ®Google Scholar
• Chung YW, Han DS, Park KH, Eun CS, Yoo KS, Park CK. 2008. Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea. Dis Colon Rectum. 51:593–597.
   PubMed Web of Science ®Google Scholar
• Currie CJ, Poole CD, Gale EA. 2009. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 52:1766–1777.
   PubMed Web of Science ®Google Scholar
• Decensi A, Puntoni M, Goodwin P, Cazzaniga M, Gennari A, Bonanni B, Gandini S. 2010. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res (Phila). 3:1451–1461.
   PubMed Web of Science ®Google Scholar
• Gandini S, Puntoni M, Heckman-Stoddard BM, Dunn BK, Ford L, Decensi A, Szabo E. 2014. Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders. Cancer Prev Res (Phila). 7:867–885.
   PubMed Web of Science ®Google Scholar
• Giovannucci E. 2007. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 86:s836–s842.
   PubMed Web of Science ®Google Scholar
• Hardie DG. 2007. AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol. 47:185–210.
   PubMed Web of Science ®Google Scholar
• Hsieh MC, Lee TC, Cheng SM, Tu ST, Yen MH, Tseng CH. 2012. The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese. Exp Diabetes Res. 2012:413782.
   PubMedGoogle Scholar
• Hsu IR, Kim SP, Kabir M, Bergman RN. 2007. Metabolic syndrome, hyperinsulinemia, and cancer. Am J Clin Nutr. 86:s867–s871.
   PubMed Web of Science ®Google Scholar
• Inoki K, Zhu T, Guan KL. 2003. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 115:577–590.
   PubMed Web of Science ®Google Scholar
• Kim YI. 1998. Diet, lifestyle, and colorectal cancer: is hyperinsulinemia the missing link? Nutr Rev. 56:275–279.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Orsini N, Wolk A. 2005. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 97:1679–1687.
   PubMed Web of Science ®Google Scholar
• Lee MS, Hsu CC, Wahlqvist ML, Tsai HN, Chang YH, Huang YC. 2011. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals. BMC Cancer. 11:20.
   PubMed Web of Science ®Google Scholar
• Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, Evans JM. 2009. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care. 32:1620–1625.
   PubMed Web of Science ®Google Scholar
• Noto H, Goto A, Tsujimoto T, Noda M. 2012. Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis. PLoS One. 7:e33411.
   PubMed Web of Science ®Google Scholar
• Oliveria SA, Koro CE, Ulcickas Yood M, Sowell M. 2008. Cancer incidence among patients treated with antidiabetic pharmacotherapy. Diabetes Metab Syndr. 2:47–57.
   Google Scholar
• Ruiter R, Visser LE, van Herk-Sukel MP, Coebergh JW, Haak HR, Geelhoed-Duijvestijn PH, Straus SM, Herings RM, Stricker BH. 2012. Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study. Diabetes Care. 35:119–124.
   PubMed Web of Science ®Google Scholar
• Siegel R, Desantis C, Jemal A. 2014. Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
   PubMed Web of Science ®Google Scholar
• Soranna D, Scotti L, Zambon A, Bosetti C, Grassi G, Catapano A, La Vecchia C, Mancia G, Corrao G. 2012. Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. Oncologist. 17:813–822.
   PubMed Web of Science ®Google Scholar
• Towler MC, Hardie DG. 2007. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res. 100:328–341.
   PubMed Web of Science ®Google Scholar
• Tsilidis KK, Capothanassi D, Allen NE, Rizos EC, Lopez DS, van Veldhoven K, Sacerdote C, Ashby D, Vineis P, Tzoulaki I, et al. 2014. Metformin does not affect cancer risk: a cohort study in the U.K. Clinical practice research datalink analyzed like an intention-to-treat trial. Diabetes Care. 37:2522–2532.
   PubMed Web of Science ®Google Scholar
• Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. (2011). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; [cited 2014]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
   Google Scholar
• Xu H, Aldrich MC, Chen Q, Liu H, Peterson NB, Dai Q, Levy M, Shah A, Han X, Ruan X, et al. 2014. Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality. J Am Med Inform Assoc. 22:179–191.
   PubMed Web of Science ®Google Scholar
• Yang YX, Hennessy S, Lewis JD. 2004. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology. 127:1044–1050.
   PubMed Web of Science ®Google Scholar
• Zhang ZJ, Zheng ZJ, Kan H, Song Y, Cui W, Zhao G, Kip KE. 2011. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis. Diabetes Care. 34:2323–2328.
   PubMed Web of Science ®Google Scholar
• Zheng ZX, Zheng RS, Zhang SW, Chen WQ. 2014. Colorectal cancer incidence and mortality in china, 2010. Asian Pac J Cancer Prev. 15:8455–8460.
   PubMedGoogle Scholar